{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:40:50Z","timestamp":1790516450408,"version":"4.1.0"},"publisher-location":"Cham","reference-count":30,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030344597","type":"print"},{"value":"9783030344610","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-3-030-34461-0_21","type":"book-chapter","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T18:02:36Z","timestamp":1577815356000},"page":"169-176","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Fatal Alliance of Hypoxia-\/HIF-1\u03b1-Driven Microenvironmental Traits Promoting Cancer Progression"],"prefix":"10.1007","author":[{"given":"Peter","family":"Vaupel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Multhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,1]]},"reference":[{"key":"21_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0076-6879(04)81023-1","volume":"381","author":"P Vaupel","year":"2004","unstructured":"Vaupel P, Mayer A, H\u00f6ckel M (2004) Tumor hypoxia and malignant progression. Methods Enzymol 381:335\u2013354","journal-title":"Methods Enzymol"},{"key":"21_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","volume":"26","author":"P Vaupel","year":"2007","unstructured":"Vaupel P, Mayer A (2007) Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26:225\u2013239","journal-title":"Cancer Metastasis Rev"},{"key":"21_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/978-1-4614-7411-1_28","volume":"789","author":"A Mayer","year":"2013","unstructured":"Mayer A, Vaupel P (2013) Hypoxia, lactate accumulation, and acidosis: siblings or accomplices driving tumor progression and resistance to therapy? Adv Exp Med Biol 789:203\u2013209","journal-title":"Adv Exp Med Biol"},{"key":"21_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00066-016-0948-1","volume":"192","author":"P Vaupel","year":"2016","unstructured":"Vaupel P, Multhoff G (2016) Adenosine can thwart antitumor immune responses elicited by radiotherapy. Strahlenther Onkol 192:279\u2013287","journal-title":"Strahlenther Onkol"},{"key":"21_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/978-3-319-91287-5_27","volume":"1072","author":"P Vaupel","year":"2018","unstructured":"Vaupel P, Multhoff G (2018) Hypoxia-\/HIF-1\u03b1-driven factors of the tumor microenvironment impeding antitumor immune responses and promoting malignant progression. Adv Exp Med Biol 1072:171\u2013176","journal-title":"Adv Exp Med Biol"},{"key":"21_CR6","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.3389\/fimmu.2017.01887","volume":"8","author":"P Vaupel","year":"2017","unstructured":"Vaupel P, Multhoff G (2017) Accomplices of the hypoxic tumor microenvironment compromising antitumor immunity: adenosine, lactate, acidosis vascular endothelial growth factor, potassium ions, and phosphatidylserine. Front Immunol 8:1887","journal-title":"Front Immunol"},{"key":"21_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bbcan.2018.07.002","volume":"1870","author":"D Samanta","year":"2018","unstructured":"Samanta D, Semenza GL (2018) Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors. Biochim Biophys Acta 1870:15\u201322. \nhttps:\/\/doi.org\/10.1016\/j.bbcan.2018.07.002","journal-title":"Biochim Biophys Acta"},{"key":"21_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bbcan.2018.06.005","volume":"1870","author":"L Sun","year":"2018","unstructured":"Sun L, Suo C, Li SF et al (2018) Metabolic reprogramming for cancer cells and their micro-environment. Beyond the Warburg effect. Biochim Biophys Acta 1870:51\u201366. \nhttps:\/\/doi.org\/10.1016\/j.bbcan.2018.06.005","journal-title":"Biochim Biophys Acta"},{"key":"21_CR9","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1038\/oncosis.2015.50","volume":"5","author":"KL Eales","year":"2016","unstructured":"Eales KL, Hollinshead KER, Tennant DA (2016) Hypoxia and metabolic adaptation of cancer cells. Oncogene 5:e190. \nhttps:\/\/doi.org\/10.1038\/oncosis.2015.50","journal-title":"Oncogene"},{"key":"21_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23:27\u201347","journal-title":"Cell Metab"},{"key":"21_CR11","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1186\/s12885-018-4577-1","volume":"18","author":"H Harrison","year":"2018","unstructured":"Harrison H, Pegg HJ, Thompson J et\u00a0al (2018) HIF-1\u03b1 expressing cells induce a hypoxic-like response in neighbouring cancer cells. BMC Cancer 18:674","journal-title":"BMC Cancer"},{"key":"21_CR12","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1126\/science.1058079","volume":"292","author":"T Pfeiffer","year":"2001","unstructured":"Pfeiffer T, Schuster S, Bonhoeffer S (2001) Cooperation and competition in the evolution of ATP producing pathways. Science 292:504\u2013507","journal-title":"Science"},{"key":"21_CR13","doi-asserted-by":"publisher","unstructured":"Shestov AA, Liu X, Ser Z et al (2014) Quantitative determinants of aerobic glycolysis identifying flux through the enzyme GAPDH as a limiting step. elife 3. \nhttps:\/\/doi.org\/10.7554\/e\/Life.03342","DOI":"10.7554\/e\/Life.03342"},{"key":"21_CR14","volume-title":"Biochemical aspects of tumour growth","author":"VS Shapot","year":"1980","unstructured":"Shapot VS (1980) Biochemical aspects of tumour growth. MIR Publishers, Moscow"},{"key":"21_CR15","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nrc3278","volume":"12","author":"MB Sporn","year":"2012","unstructured":"Sporn MB, Liby KT (2012) NRF2 and cancer: the good, the bad and the importance of context. Nat Rev Cancer 12:564\u2013571","journal-title":"Nat Rev Cancer"},{"key":"21_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4331\/wjbc.v6.i3.148","volume":"6","author":"M Lee","year":"2015","unstructured":"Lee M, Yoon JH (2015) Metabolic interplay between glycolysis and mitochondrial oxidation. The reverse Warburg effect and its therapeutic implication. World J Biol Chem 6:148\u2013161","journal-title":"World J Biol Chem"},{"key":"21_CR17","first-page":"119","volume":"38","author":"I San-Millan","year":"2017","unstructured":"San-Millan I, Brooks GS (2017) Reexamining cancer metabolism: lactate production for carcinogenesis could be the purpose and explanation of the Warburg effect. Carcinogenesis 38:119\u2013133","journal-title":"Carcinogenesis"},{"key":"21_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3389\/fimmu.2018.00040","volume":"9","author":"S Sormendi","year":"2018","unstructured":"Sormendi S, Wielockx B (2018) Hypoxia pathway proteins as central mediators of metabolism in the tumor cells and their microenvironment. Front Immunol 9:40","journal-title":"Front Immunol"},{"key":"21_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fimmu.2016.00052","volume":"7","author":"S Romero-Garcia","year":"2016","unstructured":"Romero-Garcia S, Moreno-Altamirano MMB, Prado-Garcia H et al (2016) Lactate contri-bution to the tumor microenvironment: mechanisms, effects on immune cells and therapeutic relevance. Front Immunol 7:52","journal-title":"Front Immunol"},{"key":"21_CR20","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrc.2017.77","volume":"17","author":"C Corbet","year":"2017","unstructured":"Corbet C, Feron O (2017) Tumour acidosis: from the passenger to the driver\u2019s seat. Nat Rev Cancer 17:577\u2013593","journal-title":"Nat Rev Cancer"},{"key":"21_CR21","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s00262-018-2195-z","volume":"67","author":"R Lacroix","year":"2018","unstructured":"Lacroix R, Rozeman EA, Kreutz M et al (2018) Targeting tumor-associated acidity in cancer immunotherapy. Cancer Immunol Immunother 67:1331\u20131348. \nhttps:\/\/doi.org\/10.1007\/s00262-018-2195-z","journal-title":"Cancer Immunol Immunother"},{"key":"21_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jdsr.2017.08.003","volume":"54","author":"Y Kato","year":"2018","unstructured":"Kato Y, Maeda Z, Suzuki A et al (2018) Cancer metabolism: new insights into classic characteristics. Jap Dental Sci Rev 54:8\u201321","journal-title":"Jap Dental Sci Rev"},{"key":"21_CR23","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.4161\/cc.9.17.12731","volume":"9","author":"G Bonuccelli","year":"2010","unstructured":"Bonuccelli G, Tsirigos A, Whitaker-Menezes D et al (2010) Ketones and lactate \u201cfuel\u201d tumor growth and metastasis: evidence that epithelial cancer cells use oxidative mitochondrial metabolism. Cell Cycle 9:3506\u20133514","journal-title":"Cell Cycle"},{"key":"21_CR24","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.4161\/cc.10.8.15330","volume":"10","author":"UE Martinez-Outschoorn","year":"2011","unstructured":"Martinez-Outschoorn UE, Prisco M, Ertel A et al (2011) Ketones and lactate increase cancer cell \u201cstemness\u201d, driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via Metabolo-genomics. Cell Cycle 10:1271\u20131286","journal-title":"Cell Cycle"},{"key":"21_CR25","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.4161\/cc.22137","volume":"11","author":"UE Martinez-Outschoorn","year":"2012","unstructured":"Martinez-Outschoorn UE, Lin Z, Whitaker-Menezes D et al (2012) Ketone body utilization drives tumor growth and metastasis. Cell Cycle 11:3964\u20133971","journal-title":"Cell Cycle"},{"key":"21_CR26","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.3389\/fimmu.2018.01591","volume":"9","author":"Y Li","year":"2018","unstructured":"Li Y, Patel SP, Roszik J et\u00a0al (2018) Hypoxia-driven immunosuppressive metabolites in the tumor microenvironment: new approaches for combinational immunotherapy. Front Immunol 9:1591","journal-title":"Front Immunol"},{"key":"21_CR27","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3389\/fimmu.2018.00353","volume":"9","author":"S Kouidhi","year":"2018","unstructured":"Kouidhi S, Ayed FB, Elgaaied AB (2018) Targeting tumor metabolism: a new challenge to improve immunotherapy. Front Immunol 9:353","journal-title":"Front Immunol"},{"key":"21_CR28","doi-asserted-by":"publisher","first-page":"724","DOI":"10.3389\/fimmu.2018.00724","volume":"9","author":"L Wei","year":"2018","unstructured":"Wei L, Zhu S, Li M et al (2018) High indoleamine-2,3-dioxygenase is correlated with micro-vessel density and worse prognosis in breast cancer. Front Immunol 9:724","journal-title":"Front Immunol"},{"key":"21_CR29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/978-1-4939-3023-4_22","volume":"876","author":"P Vaupel","year":"2016","unstructured":"Vaupel P, Mayer A (2016) Hypoxia-driven adenosine accumulation: a crucial microenviron-mental factor promoting tumor progression. Adv Exp Med Biol 876:177\u2013183","journal-title":"Adv Exp Med Biol"},{"key":"21_CR30","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3390\/ijms19041203","volume":"19","author":"A Shimizu","year":"2018","unstructured":"Shimizu A, Zankov DP, Kurokawa M et al (2018) Vascular endothelial growth factor a exerts diverse cellular effects via small G proteins, rho and rap. Int J Mol Sci 19:1203","journal-title":"Int J Mol Sci"}],"container-title":["Advances in Experimental Medicine and Biology","Oxygen Transport to Tissue XLI"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-34461-0_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T15:31:13Z","timestamp":1594135873000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-030-34461-0_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9783030344597","9783030344610"],"references-count":30,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-34461-0_21","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"1 January 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}